Catalyst Wire Dossier Catalyst Wire Dossier

Flonoltinib Maleate Tablets

Flonoltinib maleate · Chengdu Zenitar Biomedical Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Flonoltinib Maleate Tablets, covering 2025-09-23 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolerant Patients With Medium to High Risk Myelofibrosis [Phase 2]

See pricing